Dexme-img-01.jpg (Dexme Img 01)
Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 65219-642
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 65219-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dexme-label-01.jpg (Dexme Label 01)
Label for Dexmedetomidine Injection, USP, 200 mcg (base) per 2 mL (100 mcg base per mL) intravenous injection solution. The label specifies the product must be diluted before use, discarding any unused portion. It is a 2 mL single-dose vial labeled Rx only, manufactured by Fresenius Kabi USA, LLC. The NDC is 65219-642-01.*
Dexme-label-02.jpg (Dexme Label 02)
Label for Dexmedetomidine Hydrochloride Injection, USP 200 mcg per 2 mL (100 mcg per mL) intravenous solution by Fresenius Kabi USA, LLC. The label indicates single-dose vials, 25 vials of 2 mL each, sterile, preservative free, with details on dilution and storage conditions. NDC 65219-642-02 is shown.*
Dexme-struc-01.jpg (Dexme Struc 01)
Chemical structure of dexmedetomidine hydrochloride, showing the molecular formula C13H16N2 with associated hydrochloride (HCl) and a molecular weight of 236.7.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
